Monday morning and news arrived that FDA fully approves Pfizer / BioNTech SE Coronavirus Vaccine as the first COVID-19 vaccine for prevention of #COVID19 disease in 16 years of age and older.
A simple mix up of ingredients for the Johnson & Johnson and AstraZeneca/University of Oxford coronavirus vaccines was said to occur at Emergent BioSolutions plant.
“Vaccine for the world” – COVID-19 Vaccine by Oxford University and AstraZeneca was found to be 79 % effective against symptomatic COVID-19 and 100 % effective against severe illness. New clinical study data was released from recent studies carried out in United States, Chile and Peru. Including 32,449 adult participants in all age groups (most from United States), the study participants received either two doses of the Oxford-AstraZeneca vaccine or a placebo between four-week time. The two-shot system was completely effective at preventing severe cases of illness in the new studies. Five cases of severe illness were found in the new studies – all of them had received a placebo.